Randomized, Double Blind, Multicenter, Phase II/III Study to Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children.

Trial Profile

Randomized, Double Blind, Multicenter, Phase II/III Study to Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Jan 2015

At a glance

  • Drugs GC 1107 (Primary) ; Diphtheria-tetanus vaccine
  • Indications Diphtheria; Tetanus
  • Focus Pharmacodynamics
  • Sponsors Green Cross
  • Most Recent Events

    • 22 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 29 Aug 2012 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 29 Aug 2012 Planned End Date changed from 1 Dec 2011 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top